Barbone et al. (2019) |
1082 |
Hair |
ng/g |
Bayley-III: Fine Motor scale |
18 months |
−0.03 |
−0.11 to 0.06 |
|
Barbone et al. (2019) |
1081 |
Hair |
ng/g |
Bayley-III: Gross Motor scale |
18 months |
−0.01 |
−0.07 to 0.05 |
|
Barbone et al. (2019) |
1083 |
Hair |
ng/g |
Bayley-III: Motor development |
18 months |
−0.12 |
−0.47 to 0.22 |
|
Barbone et al. (2019) |
635 |
Umbilical cord |
ng/g |
Bayley-III: Gross Motor scale |
18 months |
−0.02 |
−0.08 to 0.05 |
|
Barbone et al. (2019) |
892 |
Umbilical cord |
ng/g |
Bayley-III: Motor development |
18 months |
−0.11 |
−0.47 to 0.25 |
|
Barbone et al. (2019) |
636 |
Whole blood |
ng/g |
Bayley-III: Fine Motor scale |
18 months |
0.05 |
−0.04 to 0.15 |
|
Barbone et al. (2019) |
890 |
Whole blood |
ng/g |
Bayley-III: Gross Motor scale |
18 months |
−0.03 |
−0.09 to 0.03 |
|
Barbone et al. (2019) |
636 |
Whole blood |
ng/g |
Bayley-III: Motor development |
18 months |
0.11 |
−0.25 to 0.48 |
|
Boucher et al. (2014) |
87 |
Umbilical cord |
ln μg/L |
BSID-II: PDI |
11 months |
0.01 |
−0.24 to 0.25 |
|
Hu et al. (2016) |
410 |
Umbilical cord |
Ln μg/L |
GDS: Fine motor domain |
12 months |
−2.62 |
−7.78 to 2.55 |
|
Hu et al. (2016) |
410 |
Umbilical cord |
Ln μg/L |
GDS: Gross motor domain |
12 months |
1.95 |
−3.08 to 6.98 |
|
Hu et al. (2016) |
410 |
Whole blood |
Ln μg/L |
GDS: Fine motor domain |
12 months |
2.69 |
−3.37 to 8.74 |
|
Hu et al. (2016) |
410 |
Whole blood |
Ln μg/L |
GDS: Gross motor domain |
12 months |
3.26 |
−2.72 to 9.24 |
|
Kim Y et al. (2018) |
595 |
Umbilical cord |
μg/L |
BSID-II: PDI |
12 months |
0.14 |
−0.23 to 0.52 |
0.45 |
Kim Y et al. (2018) |
523 |
Umbilical cord |
μg/L |
BSID-II: PDI |
24 months |
0.16 |
−0.17 to 0.48 |
0.34 |
Kim Y et al. (2018) |
438 |
Umbilical cord |
μg/L |
BSID-II: PDI |
36 months |
−0.13 |
−0.55 to 0.27 |
0.53 |
Kim Y et al. (2018) |
662 |
Umbilical cord |
μg/L |
BSID-II: PDI |
6 months |
−0.2 |
−0.45 to 0.15 |
0.33 |
Kim Y et al. (2018) |
763 |
Whole blood (early pregnancy) |
μg/L |
BSID-II: PDI |
12 months |
0.3 |
−0.31 to 0.91 |
0.34 |
Kim Y et al. (2018) |
614 |
Whole blood (late pregnancy) |
μg/L |
BSID-II: PDI |
12 months |
0.27 |
−0.38 to 0.93 |
0.41 |
Kim Y et al. (2018) |
686 |
Whole blood (early pregnancy) |
μg/L |
BSID-II: PDI |
24 months |
−0.17 |
−0.74 to 0.4 |
0.56 |
Kim Y et al. (2018) |
564 |
Whole blood (late pregnancy) |
μg/L |
BSID-II: PDI |
24 months |
−0.09 |
−0.67 to 0.48 |
0.75 |
Kim Y et al. (2018) |
557 |
Whole blood (early pregnancy) |
μg/L |
BSID-II: PDI |
36 months |
−0.11 |
−0.7 to 0.47 |
0.70 |
Kim Y et al. (2018) |
460 |
Whole blood (late pregnancy) |
μg/L |
BSID-II: PDI |
36 months |
−0.58 |
−1.19 to 0.03 |
0.06 |
Kim Y et al. (2018) |
847 |
Whole blood (early pregnancy) |
μg/L |
BSID-II: PDI |
6 months |
−0.55 |
−1.05 to −0.05 |
0.03 |
Kim Y et al. (2018) |
689 |
Whole blood (late pregnancy) |
μg/L |
BSID-II: PDI |
6 months |
−0.27 |
−0.78 to 0.25 |
0.31 |
Llop et al. (2012) |
1683 |
Umbilical cord |
Ln µg/L |
BSID-II: PDI |
14 months |
−0.05 |
−0.79 to 0.68 |
|
Nisevic et al. (2019) |
257 |
Umbilical cord |
μg/L |
Bayley-III: Fine Motor scale |
18 months |
−0.07 |
|
0.78 |
Nisevic et al. (2019) |
257 |
Umbilical cord |
μg/L |
Bayley-III: Gross Motor scale |
18 months |
0.08 |
|
0.71 |
Nisevic et al. (2019) |
257 |
Umbilical cord |
μg/L |
Bayley-III: Motor development |
18 months |
0.01 |
|
0.92 |
Oken et al. (2008) |
341 |
Erythrocyte |
ng/g |
WRAVMA drawing |
36 months |
0.1 |
−0.2 to 0.4 |
|
Oken et al. (2008) |
341 |
Erythrocyte |
ng/g |
WRAVMA pegboard |
36 months |
0.03 |
−0.3 to 0.3 |
|
Rothenberg et al. (2016) |
270 |
Hair |
Ln μg/g |
BSID-II: PDI |
12 months |
−2.7 |
−8.3 to 2.9 |
|
Tatsuta et al. (2017) |
566 |
Umbilical cord |
Ln ng/g |
BSID-II: PDI |
18 months |
−0.12 |
|
0.009 |
Valent et al. (2013) |
505 |
Hair |
Ln ng/g |
Bayley-III: Motor development |
18 months |
−0.19 |
|
0.62 |
Valent et al. (2013) |
378 |
Umbilical cord |
Ln ng/g |
Bayley-III: Motor development |
18 months |
0.16 |
|
0.68 |
Xu et al. (2016) |
270 |
Umbilical cord |
μg/L |
NNNS: Asymmetry (Male) |
5 weeks |
0.1 |
|
0.36 |
Xu et al. (2016) |
270 |
Umbilical cord |
μg/L |
NNNS: Asymmetry (Female) |
5 weeks |
0.07 |
|
0.4 |
Xu et al. (2016) |
270 |
Umbilical cord |
μg/L |
NNNS: Handling |
5 weeks |
−0.02 |
|
0.35 |
Xu et al. (2016) |
344 |
Whole blood |
μg/L |
NNNS: Asymmetry (Male) |
5 weeks |
−0.13 |
|
0.3 |
Xu et al. (2016) |
344 |
Whole blood (Female) |
μg/L |
NNNS: Asymmetry (Female) |
5 weeks |
0.08 |
|
0.43 |
Xu et al. (2016) |
344 |
Whole blood |
μg/L |
NNNS: Handling |
5 weeks |
−0.001 |
|
0.98 |